CIT v. Claris Lifesciences Ltd.

326 ITR 251High Court2010#476 most cited

What is CIT v. Claris Lifesciences Ltd. authority for?

If approval from the Department of Scientific and Industrial Research (DSIR) for an in-house R&D centre is granted during the previous year, the assessee is entitled to claim weighted deduction under section 35(2AB) for the entire expenditure incurred during that year.

196

judgments rely on this decision, according to BharatTax’s citation analysis of 366,470 Indian tax judgments — from 2011 to 2026.

Also referred to as

CIT v. Claris Lifesciences Ltd. · 326 ITR 251 · Section 35(2AB) · weighted deduction · scientific research expenditure · R&D centre approval · DSIR approval timing · eligibility for entire expenditure · in-house R&D · previous year expenditure

Also reported as

174 Taxmann 11320 Taxmann.com 682

Issues it is cited on

Judgments citing CIT v. Claris Lifesciences Ltd.

Salvi Chemicals Industries Ltd, Mumbai vs. ACIT Cir 13(2)(1), Mumbai

In the result, the appeal filed by the assessee is hereby allowed

ITA 300/MUM/2019[2014-15]Status: DisposedITAT Mumbai20 Oct 2021AY 2014-15

Bench: Shri Amarjit Singh, Jm & Shri Manoj Kumar Aggarwal, Am (Hearing Through Video Conferencing Mode) आयकर अपील सं/ I.T.A. No. 300/Mum/2019 (निर्धारण वर्ा / Assessment Year: 2014-15) M/S. Salvi Chemicals बिधम/ Acit-13(2)(1) Industries Ltd. Aayakar Bhavan, Mumbai- Vs. C/O. H.N. Motiwalla & Co. 400020. 508 Sharda Chambers 33 New Marine Lines, Mumbai-400020. स्थायी लेखा सं./जीआइआर सं./Pan/Gir No. : Aakcs0142E (अपीलाथी /Appellant) .. (प्रत्यथी / Respondent) Assessee By: Shri Harish Motiwalla (Ar) Revenue By: Shri T. S. Khalsa (Dr) सुनवाई की तारीख / Date Of Hearing: 14/09/2021 घोषणा की तारीख /Date Of Pronouncement: 20/10/2021 आदेश / O R D E R Per Amarjit Singh, Jm: The Assessee Has Filed The Present Appeal Against The Order Dated 12.09.2018 Passed By The Commissioner Of Income Tax (Appeals) -21, Mumbai [Hereinafter Referred To As The “Cit(A)”] Relevant To The A.Y.2014- 15. 2. The Assessee Has Raised The Following Grounds: - “1. On The Facts & In The Circumstances Of The Case, The Learned Commissioner Of Income Tax (Appeals) -21, Mumbai Erred In Confirming The Order Of The Assessing Officer In Respect Of Disallowance Of Research & Development Expenses Under Section A.Y. 2014-15 36(1)(Iv) R.W.S 36 (2Ab) Of The Act, Amounting To Rs, 1,88,97,692/-, Particularly When, The Order Under Section 35(2Ab) Of The Act (In Form No. 3Cm) Had Been Granted Registration Upto March 31,2012 & Renewed Upto March 31, 2015. 2. On The Facts & In The Circumstances Of The Case, The Said Learned Commissioner Of Income Tax, Mumbai, Erred In Confirming The Order Of The Assessing Officer In Respect Of Disallowance Of Research & Development Expenses Amounting To Rs. 1,88,97,692/ Under Section 35(1)(Iv) R.W.S. 35 (2Ab) Of The Act, Without Appreciating The Decisions Submitted At The Time Of Hearing Or Without Distinguishing The Same.

For Appellant: Shri Harish Motiwalla (AR)For Respondent: Shri T. S. Khalsa (DR)
Section 143(2)Section 14ASection 35Section 35(1)(iv)

…35(1)(iv) and 35(2AB) was declined which is wrong against law and facts, therefore, the claim of the assessee is liable to be allowed in view of the law settled as under:- “(i) Judgment of Gujarat High Court in the case of CIT Vs. Claris Life Sciences Ltd. (326 ITR 251) (ii) Judgment of Gujarat High Court in the case of Banco Products (India) Ltd. Vs. DCIT (405 ITR 318) (iii) Judgment of Delhi High Court in the case of Maruti Suzuki India Ltd. Vs. Union of India & Others (397 ITR 728) (iv) Decision of Mumbai Tribunal in ACIT, Cir. 6(3) Vs. Meco Instruments Pvt. Ltd. (ITA. No.4246/Mum/2009) dated August 20,2010…

M/S. Fdc Limited, Mumbai vs. Addll. CIT- 8 (1), Mumbai

Appeal stand dismissed

ITA 6901/MUM/2018[2010-11]Status: DisposedITAT Mumbai08 Oct 2021AY 2010-11

Bench: Hon’Ble Shri Mahavir Singh, Vp & Hon’Ble Shri Manoj Kumar Aggarwal, Am (Hearing Through Video Conferencing Mode) 1. आयकरअपील िं./ I.T.A. No.6901/Mum/2018 (धििाारण वर्ा / Assessment Year: 2010-11) & 2. आयकरअपील िं./ I.T.A. No.6840/Mum/2018 (धििाारण वर्ा / Assessment Year: 2011-12) M/S Fdc Limited Acit Circle– 8(1) बिाम/ 142-48, S. V. Road {Now Acit Circle 9(3)(1)} Jogeshwari (West) R. No. 215, Aayakar Bhavan Vs. Mumbai – 400 102 Mumbai-400 020 स्थायीलेखा िं./ जीआइआर िं./ Pan/Gir No. Aaacf-0253-H (अपीलाथी/Appellant) (प्रत्यथी / Respondent) : & 3. आयकरअपील िं./ I.T.A. No.7016/Mum/2018 (धििाारण वर्ा / Assessment Year: 2010-11) Acit Circle– 8(1) M/S Fdc Limited बिाम/ {Now Acit Circle 9(3)(1)} 142-48, S. V. Road R. No. 215, Aayakar Bhavan Jogeshwari (West) Vs. Mumbai-400 020 Mumbai – 400 102 स्थायीलेखा िं./ जीआइआर िं./ Pan/Gir No. Aaacf-0253-H (अपीलाथी/Appellant) (प्रत्यथी / Respondent) : Assessee By : Shri S. S. Nagar, Ld. Ar Revenue By : Shri Sunil Deshpande, Ld. Cit-Dr ुनवाई की तारीख/ : 20/07/2021 Date Of Hearing घोषणा की तारीख / : 08/10/2021 Date Of Pronouncement

For Appellant: Shri S. S. Nagar, Ld. ARFor Respondent: Shri Sunil Deshpande, Ld. CIT-DR
Section 143(3)Section 154Section 92C

…r the period from 01/4/2004 to 31/03/2007 as well as for the period from 01/04/2012 to 31/03/2015 for all its R&D Units (Pg. 426 to 429 of Paper Book- 2). In such a case, the ratio of decision of Hon’ble Gujarat High Court in CIT V/s Claris Lifesciences Ltd. (326 ITR 251) would squarely apply in favor of the assessee. In this decision, it has been held by Hon’ble Court that the approval of R&D facility by DSIR is sufficient to claim deduction u/s 35(2AB). This decision has been followed by coordinate bench of Mumbai Tribunal in Advance Enzyme Technologies P Ltd V/s ACIT (2020; 116 Taxmann.com 498) wherein it has…